Simple Summary The development of nanotechnology has brought revolution to the
diagnosis and therapy of diseases, with a high precision and efficacy. Because …

With the advent of the era of precision medicine, prostate‐specific membrane antigen
(PSMA)‐targeted theranostic strategies have had a profound impact on prostate cancer …

The Precision Medicine Initiative aims to use advances in basic and clinical research to
develop therapeutics that selectively target and kill cancer cells. Under the same doctrine of …

Prostate-specific membrane antigen (PSMA), a transmembrane glycoprotein located on the
cell membrane, is specifically and highly expressed in prostate cancer (PCa). Besides, its …

Cancer is a group of diseases responsible for the major causes of mortality and morbidity
among people of all ages. Even though medical sciences have made enormous growth …

Prostate cancer is one of the most common cancers and among the leading causes of
cancer deaths in the United States. Men diagnosed with the disease typically undergo …

The prostate-specific membrane antigen (PSMA) is a molecular target whose use has
resulted in some of the most productive work toward imaging and treating prostate cancer …

The high incidence rates of prostate cancer (PCa) raise demand for improved therapeutic
strategies. Prostate tumors specifically express the prostate‐specific membrane antigen …

Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is highly
expressed in aggressive prostate cancer (PCa) and has been extensively studied as a PCa …

Fluorescence imaging is an emerging technology that can provide real-time information
about the operating field during cancer surgery. Non-specific fluorescent agents, used for …